WILEX AG

 

 

ENGLISH DEUTSCH

Focused on oncology, WILEX develops diagnostic and therapeutic product candidates based on antibodies, which are available for out-licensing. The subsidiary Heidelberg Pharma GmbH offers preclinical contract research services and an antibody drug conjugate (ADC) technology platform.

 

Latest News

23.04.2015: Results of Heidelberg Pharma’s research cooperation with M.D. Anderson Cancer Center published in Nature journal....More

14.04.2015: WILEX publishes 3-month Financial Report. ....More

 

 

Seite gelesen: 298242 | Heute: 311